Hematologic toxicity and double autografting of stem cells after myeloablative activities of Yttrium-90-Ibritumomab tiuxetan

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1145-1146
Number of pages2
JournalJournal of Clinical Oncology
Volume27
Issue number7
DOIs
Publication statusPublished - Mar 1 2009

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this